Sarepta price target raised to $209 from $203 at Barclays

Barclays raised the firm’s price target on Sarepta (SRPT) to $209 from $203 and keeps an Overweight rating on the shares. The company reported a big Q3 beat on both total and Elevidys revenue, the analyst tells investors in a research note. The firm says Sarepta’s reiterated guidance for Elevidys “appeared too conservative.”